New Findings in Anemia Described from Tampa General Hospital

[1gemstone]

 

By a News Reporter-Staff News Editor at Biotech Week — Researchers detail new data in Hematologic Diseases. According to news reporting originating from Tampa, Florida, by NewsRx correspondents, research stated, “Management of severe symptomatic anemia in critically ill Jehovah’s Witness patients remains a challenge. The paucity of therapeutic alternatives to human red blood cells has prompted the use of blood substitutes.”

Our news editors obtained a quote from the research from Tampa General Hospital, “A 19-year-old female Jehovah’s Witness patient presented to the emergency department following several episodes of syncope. She was found to have a positive Coombs test and was diagnosed with warm-bodied autoimmune hemolytic anemia. Upon admission, her hemoglobin was 8.4 g/dL, then dropped to a nadir of 2.8 g/dL 4 days later. She received traditional management with corticosteroids, intravenous immune globulin, rituximab, and partial splenic artery embolization. Despite these therapies, hemoglobin levels failed to respond, and she experienced signs of marked ischemia. A decision was made to give 2 units of Hemopure, a bovine hemoglobin-based oxygen carrier, and the hemoglobin levels increased to 8.7 g/dL 10 days later. The patient’s overall clinical condition improved leading to subsequent hospital discharge. This case exemplifies the ingenuity that health care practitioners mus use in critical situations involving the medical management of anemic Jehovah’s Witness patients who refuse blood products.”

According to the news editors, the research concluded: “Hemopure was used as ‘bridging treatment’ to help save a patient from the devastating effects of ischemia resulting from severe anemia.”

For more information on this research see: Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah’s Witness patient with autoimmune hemolytic anemia. Journal of Pharmacy Practice, 2013;26(3):257-60. Journal of Pharmacy Practice can be contacted at: SAGE Publications, USA , 2455 Teller Road, Thousand Oaks, CA 91320, USA. (Sage Publications – www.sagepub.com/; Journal of Pharmacy Practice – jpp.sagepub.com)

The news editors report that additional information may be obtained by contacting S.D. Jordan, Tampa General Hospital, Tampa, FL, United States (see also Hematologic Diseases).

Publisher contact information for the Journal of Pharmacy Practice is: SAGE Publications, USA , 2455 Teller Road, Thousand Oaks, CA 91320, USA.

Keywords for this news article include: Tampa, Florida, Immunology, Hemoglobins, Therapeutics, United States, Blood Proteins, Autoimmune Diseases, Autoimmune Disorders, Hematologic Diseases, North and Central America, Autoimmune Hemolytic Anemia, Hemic and Lymphatic Diseases.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC

Source: HispanicBusiness

http://www.hispanicbusiness.com/2013/9/18/new_findings_in_anemia_described_from.htm

Article taken from Jehovah's Witnesses News - http://www.tdgnews.it/en
URL 

[feather]

appreciate your post Missy

   TGH is minutes away from me here in Fl

    they have an excellent reputation

     for bloodless surgery in this area

     http://www.tgh.org/bloodless.htm

[bogartd]

Why couldn't something like this be used on our young brother almost turning 18, that the courts ruled against him declining a blood transfusion because of leukemia ?  I believe he has. He told them that if they forced a  blood transfusion on him against his will then it would be like rape. And I for one have to agree with him. May Jehovah bless him for his faithfulness.

[cricket246]

Just curious...I'm still learning about all of this bloodless technology...what does a "bovine hemoglobin-based oxygen carrier" mean? Is it a substance derived from a cow?   Just curious lol

Edited September 30, 2013 by cricket246